Pre-eclampsia Resources

Information About Biophysical Markers

Best results in screening for elevated risk of pre-eclampsia are being achieved by using PlGF in combination with other parameters. The biophysical markers, Mean Arterial Pressure (MAP) and Uterine Artery Pulsatility Index (PI) are much discussed in this respect. We have gathered some useful information on these markers, and it is found under the respective links.

Research on Therapies

Guidelines on pre-eclampsia prevention already make recommendations on the treatment of pregnancies judged to be at risk. The administration of low-dose aspirin started at an early stage of pregnancy is one of the suggested therapies attracting research interest. Notes on Therapy Research are under the link.

PerkinElmer products for pre-eclampsia are not available in all countries. For information on availability please contact your local sales representative.

Information provided within the Overview of Pre-eclampsia is for information purposes only and not intended to be construed as medical guidance. Always contact your healthcare professional for assessment and direction regarding your health.

Customer Care

Connect

NOTICE: You are now leaving the PerkinElmer website. The privacy policy of the site to which you are going may differ from PerkinElmer's privacy policy. To remain at the PerkinElmer site and return to your previous page, click the button Cancel. To leave the PerkinElmer site for the link you selected, click the button OK.